Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of Diagnostics to Identify Glucose-6-phosphate Dehydrogenase Activity in the US

NCT04010695 is registered in ClinicalTrials.gov with PATH as lead sponsor.

NCT NCT04010695
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04010695 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of Diagnostics to Identify Glucose-6-phosphate Dehydrogenase Activity in the US
Lead sponsor
PATH
Phase
Not applicable
Overall status
Completed
Start date
May 13, 2019
Completion date
September 19, 2019
Enrollment
250 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

g6pd deficiency